Benitec Biopharma Ltd ADR (BNTC)
Healthcare
Biotechnology
11.70 $
-1.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Benitec Biopharma Ltd ADR (BNTC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 52.2% of the shares are freely tradable; institutional investors hold 98.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
98.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
2.7%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
52.2%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
12.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
34Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 33.62 | 11,548,351 | +0.0 | 03/31/2026 |
| HHG PLC | 8.37 | 2,876,380 | -1.2 | 03/31/2026 |
| Franklin Resources Inc | 6.92 | 2,378,159 | +8.2 | 03/31/2026 |
| Adage Capital Partners Gp LLC | 6.17 | 2,120,672 | +0.0 | 03/31/2026 |
| RA Capital Management, LLC | 5.39 | 1,850,000 | +0.0 | 03/31/2026 |
| Nantahala Capital Management, LLC | 4.19 | 1,438,371 | +38.5 | 03/31/2026 |
| BlackRock Inc | 3.45 | 1,185,741 | +19.5 | 03/31/2026 |
| Vanguard Group Inc | 3.42 | 1,174,758 | +18.4 | 12/31/2025 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| HBM Healthcare Investments AG Ord | 3.47 | 1,191,669 | +0.0 | 03/31/2026 |
| Franklin Biotechnology Discv A(acc)USD | 2.90 | 997,476 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.